Detalhe da pesquisa
1.
Influence of UGT1A1 and SLC22A6 polymorphisms on the population pharmacokinetics and pharmacodynamics of raltegravir in HIV-infected adults: a NEAT001/ANRS143 sub-study.
Pharmacogenomics J
; 23(1): 14-20, 2023 01.
Artigo
Inglês
| MEDLINE | ID: mdl-36266537
2.
A retrospective observational study to evaluate the clinical outcomes and routine management of patients with chronic lymphocytic leukaemia treated with idelalisib and rituximab in the UK and Ireland (RETRO-idel).
Br J Haematol
; 194(1): 69-77, 2021 07.
Artigo
Inglês
| MEDLINE | ID: mdl-34121184
3.
Population pharmacokinetics and pharmacogenetics of ritonavir-boosted darunavir in the presence of raltegravir or tenofovir disoproxil fumarate/emtricitabine in HIV-infected adults and the relationship with virological response: a sub-study of the NEAT001/ANRS143 randomized trial.
J Antimicrob Chemother
; 75(3): 628-639, 2020 03 01.
Artigo
Inglês
| MEDLINE | ID: mdl-31754703